Consulting > Asan Preclinical Evaluation center for cancer therapeutiX

  • Clinical utility assessment by oncology specialists and clinical development strategy establishment from the early stages of drug development
  • Bridging the gap between clinical demands and oncological innovation through scientific interpretation by translational research experts
  • Strategic planning for a one-stop service, covering from preclinical to clinical trials

  • Service

    Clinical Oncologist Consulting (Cancer Type-Specific)

    • Develop commercialization strategies targeting unmet medical needs
    • Design IND and non-clinical efficacy evaluation strategies tailored to the drug development stage

    Non-Clinical Efficacy Evaluation Consulting

    • Mechanism of action validation
    • Development of non-clinical study strategies
    • Customized model development for efficacy evaluation
    • Study design based on patient-derived models

    Preclinical and Early Clinical Consulting

    • Preclinical GLP studies and early-phase clinical trials strategies
    • Interpretation of toxicokinetics, clinical pathology, and histopathology data
    • Preclinical GLP toxicology study design and support
    • PK/PD modeling and simulation analysis
    • Pharmacokinetics (PBPK) modeling to predict human pharmacokinetics and therapeutic outcomes
    • Regulatory strategy development for CMC (Chemistry, Manufacturing, and Controls)
    • Pre-IND Meeting Support
    • Early clinical strategy development, including first-in-human (FIH) and proof-of-concept (POC) studies
    • Risk management for preclinical-phase issues
    • Regulatory preparation strategies